In the News

134 News Items found
MSK surgeons gathered around a robot used for cancer surgery
Q&A
Department of Surgery Chair Jeffrey Drebin discusses MSK’s approach to robotic surgery in response to a recent FDA advisory.
Dr. Prasad Adusumilli sits at a computer. A patient’s face and a chest image are on the screen.
Feature
Whether you’ve been diagnosed with a rare cancer or one that’s more common, MSK doctors can provide a second opinion.
Maureen Sideris is seen smiling with her sister Marion.
Learn about a clinical trial that used immunotherapy alone to treat people with several different types of cancer, meaning they did not need to undergo surgery, radiation, or chemotherapy.
Pouring white wine into a glass
Feature
Hear from our experts about a new study linking alcohol consumption and melanoma risk.
Luis Alberto Diaz Jr.
President Biden announced on September 15 his appointment of MSK medical oncologist and Head of the Division of Solid Tumor Oncology, Luis Alberto Diaz, Jr., MD, as one of seven distinguished members of the National Cancer Advisory Board.
Breast medical oncologist Sherry Shen is seen smiling outdoors.
Learn what Zepbound, Wegovy, Ozempic and other weight loss drugs mean for cancer risk and treatment, from an expert at MSK.
MSK patient Dario Cortes
Feature
How Rectal Cancer Taught Dario Resilience
Meet Dario Cortes, who was treated for rectal cancer at Memorial Sloan Kettering and is now back to doing the activities he loves.
MSK-IMPACT
Fifty years ago, the signing of the National Cancer Act ushered in a new era of cancer research and care.
Dr. Zsofia Stadler
Finding
An analysis of patients with Lynch syndrome treated at MSK finds that immunotherapy drugs called checkpoint inhibitors may prevent serious tumors from forming.
Dr. Robin Mendelsohn
The United States Preventive Services Task Force released updated draft recommendations on colorectal cancer screening which, among other things, call for screening for the general population to begin at age 45.